CG0070

Generic Name
CG0070
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
-
CAS Number
-
Unique Ingredient Identifier
-
Background

CG0070 is investigated in clinical trials for treating bladder cancer. CG0070 is a solid. CG0070 can potentially destroy cancer cells by two different mechanisms: direct cell killing by the virus and immune-mediated cell killing stimulated by GM-CSF. CG0070, an oncolytic virus therapy with specificity for multiple cancers, has been evaluated in numerous preclinical studies. It has been engineered to secrete GM-CSF, an immune stimulating hormone, which also serves as the adjuvant in cancer immunotherapy.

Indication

Investigated for use/treatment in bladder cancer.

Associated Conditions
-
Associated Therapies
-

Study of CG0070 After Transurethral Resection in Patients With IR NMIBC

Phase 1
Recruiting
Conditions
Interventions
First Posted Date
2024-02-12
Last Posted Date
2024-12-24
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
20
Registration Number
NCT06253845
Locations
🇺🇸

Moffitt Cancer Center, Tampa, Florida, United States

Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC

Phase 1
Active, not recruiting
Conditions
Interventions
First Posted Date
2020-10-30
Last Posted Date
2024-12-13
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
21
Registration Number
NCT04610671
Locations
🇺🇸

Moffitt Cancer Center, Tampa, Florida, United States

Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin

First Posted Date
2020-05-13
Last Posted Date
2022-08-24
Lead Sponsor
CG Oncology, Inc.
Target Recruit Count
35
Registration Number
NCT04387461
Locations
🇺🇸

Moffitt Cancer Center, Tampa, Florida, United States

🇺🇸

Northwestern University, Tampa, Florida, United States

🇺🇸

Johns Hopkins Medical Institution, Baltimore, Maryland, United States

and more 16 locations
© Copyright 2024. All Rights Reserved by MedPath